Latest News

If you are wondering whether Hyatt Hotels' share price still reflects good value, or if you are late to the story, this article will walk through what the numbers say about the stock today. Hyatt last closed at US$139.30, with a 6.9% decline over 7 days and a 17.4% decline over 30 days, while the stock shows a 14.4% return over 1 year, 33.0% over 3 years and 62.2% over 5 years. Recent headlines around Hyatt have focused on its ongoing position as a global hotel operator and the broader...

Maple Leaf Foods (TSX:MFI) is back in the spotlight after launching a new normal course issuer bid to repurchase up to 7.3 million shares, alongside new 2030 financial targets and business priorities. See our latest analysis for Maple Leaf Foods. Those plans and the fresh buyback sit against a steadily improving tape, with a 30 day share price return of 5.60%, a 90 day gain of 12.38%, and a 1 year total shareholder return of 39.50%. This suggests momentum has been building rather than...

Why K92 Mining (TSX:KNT) Is On Investors’ Radar Right Now K92 Mining (TSX:KNT) is in focus after reporting full year 2025 production at the upper end of guidance and releasing earnings that show higher sales and net income versus the prior year. See our latest analysis for K92 Mining. Even with full year 2025 production at the upper end of guidance and higher sales and net income, the recent share price has been volatile, with a 1 day share price return of 6.74% decline and a 7 day share...

JD.com (JD) just reported mixed fourth quarter and full year 2025 results, with revenue growth but a quarterly net loss as heavier marketing, R&D and new business spending, including food delivery, weighed on margins. See our latest analysis for JD.com. JD.com shares have been choppy, with a 7 day share price return of 4.77% offset against a 1 year total shareholder return decline of 32.49%. This suggests recent momentum is building after a tougher stretch for longer term holders. If JD.com's...

Dyne Therapeutics plans to submit an accelerated application for its Duchenne muscular dystrophy drug, targeting a potential commercial launch in early 2027. The company has completed enrollment in its Phase 1/2 trial in myotonic dystrophy type 1 and started a Phase 3 trial for DYNE-101 in DM1. New long term DELIVER trial data report meaningful improvements in lung and cardiac function in patients with Duchenne muscular dystrophy. For investors watching NasdaqGS:DYN, these clinical and...

If you are wondering whether Sally Beauty Holdings is still worth your attention at around US$14.54 per share, this article walks through what that price could mean for value focused investors. The stock is roughly flat year to date with a 0.3% return. However, the 59.4% return over the past year, alongside shorter term moves of a 1.7% decline over 7 days and a 4.5% decline over 30 days, suggests sentiment has shifted more than once recently. Recent coverage has focused on Sally Beauty...

Event context and recent share performance IHS Holding (NYSE:IHS) did not report a fresh headline event today, but the stock’s recent moves and fundamentals give you a few concrete markers to work with as you think about its role in your portfolio. See our latest analysis for IHS Holding. With the share price at US$8.20, IHS Holding has seen a 90 day share price return of 11.56% and a 1 year total shareholder return of 116.93%. This suggests momentum has been building over the past year,...

Buyback announcement and what it means for shareholders Canadian Tire Corporation (TSX:CTC.A) has launched a new normal course issuer bid to repurchase up to 4,700,000 Class A non voting shares, about 9.59% of its current float, through March 10, 2027. The company says the program is meant to offset dilution from its dividend reinvestment and stock option plans. The goal is to keep the share count in check rather than materially shrink it over time. See our latest analysis for Canadian Tire...

If you are trying to work out whether Lindsay's share price lines up with its underlying value, you are not alone. This article is built to help you unpack that question step by step. Lindsay's shares last closed at US$125.38, with returns of 3.5% year to date and declines of 3.3% over the past week, 6.9% over the past month, 2.8% over the past year, 6.0% over three years and 20.4% over five years. These figures may influence how investors are thinking about both growth potential and...

Earlier this week, Celcuity announced that the Journal of Clinical Oncology published Phase 3 VIKTORIA-1 results showing the gedatolisib triplet and doublet regimens substantially reduced the risk of disease progression or death versus fulvestrant alone in HR-positive, HER2-negative PIK3CA wild-type advanced breast cancer after CDK4/6 inhibitor and aromatase inhibitor therapy. The data highlight gedatolisib’s differentiated, multi-target PAM pathway inhibition, which produced a 7.3-month...

Western Midstream Partners (WES) is back in focus after revamping its long term agreement with Occidental, shifting to fixed fees with minimum volume commitments through 2035 and receiving a large share transfer in return. See our latest analysis for Western Midstream Partners. Against that backdrop, Western Midstream Partners' share price is at US$40.82, with a 90 day share price return of 3.58% and a year to date gain of 2.77%. Its 1 year total shareholder return of 9.28% sits on top of...

Earlier this week, Diodes Incorporated expanded its automotive power management lineup by launching the AL8859Q, a multi-phase SPI boost controller designed for advanced, functionally safe headlight and broader vehicle power systems, alongside a standard-compliance AL8859 version for industrial and consumer use. By combining high efficiency, tight voltage accuracy, EMI-friendly spread-spectrum modulation, and extensive diagnostics in a compact package priced at US$0.60 for 10,000-piece...

Why Sonoco Products is on investors’ radar Sonoco Products (SON) has drawn fresh attention after recent share price moves, with the stock closing at $53.32 as investors reassess its long history in packaging across consumer and industrial markets. See our latest analysis for Sonoco Products. The recent 1 day share price return of 1.1% builds on a 25.6% 90 day share price return and a 22.3% 1 year total shareholder return, suggesting momentum has been improving after a quieter multi year...

Zalando (XTRA:ZAL) has wrapped up FY 2025 with fourth quarter revenue of €4.1b and net income of €93.7m, putting fresh numbers behind the ongoing debate about its profitability and growth potential. The company has seen quarterly revenue move from €3.3b and net income of €120m in Q4 2024 to €2.4b and €9.9m in Q1 2025, €2.8b and €96.6m in Q2, €3.0b and €14.8m in Q3, before landing at €4.1b and €93.7m in Q4 2025. This has left investors focused on how consistently those earnings can translate...

A.P. Møller - Mærsk has formed a new UK defence supply chain alliance with Amentum, GXO Logistics and Accenture. The partnership focuses on defence readiness and supply chain resilience for mission critical government operations. The move extends Maersk's integrated logistics offering into higher security, technology driven contracts in the defence sector. A.P. Møller - Mærsk (CPSE:MAERSK B) is adding a new leg to its business with this defence focused alliance, alongside its core global...

Trust Platform expansion sharpens focus on security driven demand Microchip Technology (MCHP) has extended its Trust Platform with the TA101 TrustFLEX secure authentication IC and TA101 TrustMANAGER service, targeting tighter cybersecurity rules in industrial and automotive markets. These additions are built for products subject to the EU Cyber Resilience Act and for software defined vehicle architectures, giving manufacturers hardware based authentication, lifecycle key management and...

Government contract wins put Reliance (RS) in focus Reliance (RS) drew investor attention after subsidiary AMI Metals secured two sizeable U.S. government contracts, one tied to border wall steel and logistics and another supporting Lockheed Martin’s F-35 aluminum plate processing. See our latest analysis for Reliance. Despite the AMI Metals contract wins and recent broker commentary, Reliance’s share price has pulled back with a 17.5% 1 month share price return. However, the 1 year total...

Why Fair Isaac is back in focus Fair Isaac (FICO) has jumped back onto investors’ radar after two linked developments, rising pressure from rival credit scores in U.S. mortgages and a fresh US$1b senior notes issuance. Together, these moves have raised questions about how secure FICO’s core Scores business really is and how management is choosing to fund the next phase of the company’s evolution. See our latest analysis for Fair Isaac. FICO’s share price has been under pressure for several...

Fluence Energy (FLNC) is back in focus after a bullish SEIA and Wood Mackenzie report pointed to strong U.S. solar and storage installations, with solar projected to lead new grid capacity additions in 2025. See our latest analysis for Fluence Energy. Fluence Energy’s recent moves reflect a mixed picture, with a 10.83% 7 day share price return and a 26.18% 90 day share price decline, yet a very large 1 year total shareholder return suggests longer term momentum has been stronger than the...

In recent days, Danaher has come under pressure after its US$9.90 billion Masimo acquisition raised questions about higher debt levels, integration risks, and a more cautious full-year 2026 outlook amid sector headwinds. At the same time, a law firm has begun investigating potential fiduciary duty breaches by certain officers and directors, while a Danaher subsidiary, IDBS, received an industry award for biopharma digitalisation in Asia-Pacific. These developments highlight how Danaher’s...

In recent updates, Landstar System expanded its heavy haul and Mexico cross-border services while maintaining dividends, share repurchases, and a lower long-term debt load. This combination of operational expansion and financial conservatism contrasts with softer freight demand and capacity imbalances that have led analysts to trim earnings expectations. Now we’ll explore how analysts’ cautious earnings revisions, despite Landstar’s heavy haul and Mexico expansion, reshape the company’s...

If you are wondering whether BeOne Medicines at around US$284.05 is giving you fair value or a potential mispricing, this article will walk through what the current market price might be saying about the business. The stock has seen mixed returns, with a 5.7% decline over the last 7 days and a 19.1% decline over the last 30 days, set against a 27.2% return over 3 years and 9.6% over 1 year. These figures can change how investors view both its growth prospects and risk. Recent coverage of...

In recent days, Brent crude futures moved above US$100 per barrel, coinciding with heightened interest in Canadian producers like Whitecap Resources, whose low operating costs and the earlier Veren merger have increased its production scale and asset depth. This combination of stronger commodity pricing, an enlarged asset base and a continuing monthly dividend has brought fresh attention to Whitecap’s ability to generate free funds flow from its Western Canadian oil and gas portfolio. Next,...

Kadant stock moves: how recent returns stack up for long term holders Kadant (KAI) has seen mixed share performance recently, with a 5.5% decline over the past day and about 9.3% over the past month, while the past 3 months show a 3.9% gain. See our latest analysis for Kadant. Zooming out from the recent pullback, Kadant’s 1-day and 30-day share price returns of 5.5% and 9.3% declines contrast with a 6% year to date gain and a 56.2% three year total shareholder return. This suggests momentum...